STOCK TITAN

ProAssurance Corporation (PRA) 10-K Filings

PRA

Here are the 10-K annual reports from ProAssurance Corporation (PRA) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 10-K covers the audited annual report, with the full financial statements, so if you follow PRA and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full PRA filings page.

Rhea-AI Summary

ProAssurance Corporation filed Amendment No. 1 to its annual report to supply updated Part III information on directors, executive pay, ownership, related-party matters and auditor fees. The amendment adds detail on board composition, committee independence, pay philosophy and incentive structures.

The filing describes a pending merger under which ProAssurance will become a wholly owned subsidiary of The Doctors Company, noting most required regulatory approvals have been received and the companies continue to anticipate closing by June 30, 2026. It highlights a pay-for-performance design in which 77% of the CEO’s 2026 target total direct compensation is at risk, 2025 annual incentives for executives ranged from 110% to 161% of target, and 2023–2025 performance shares paid nothing because total shareholder return and book value growth did not meet threshold goals.

Rhea-AI Summary

ProAssurance Corporation files its annual report detailing its 2025 business and a pending merger with The Doctors Company. For the year, net premiums written were $0.9 billion, with total assets of $5.4 billion and shareholders’ equity of $1.3 billion as of December 31, 2025.

Gross premiums written were $1.01 billion, with about 77% from Specialty Property & Casualty, 23% from Workers’ Compensation and the remainder from Segregated Portfolio Cell Reinsurance. The report explains strategy around disciplined underwriting, claims management, and investment income, and outlines extensive risk factors spanning insurance, financial, regulatory, operational and technology risks.

The company describes its March 2025 Merger Agreement under which it would become a wholly owned subsidiary of The Doctors Company. Shareholders have approved the deal and most U.S. insurance regulatory approvals have been obtained, with California and Pennsylvania still reviewing. ProAssurance continues to anticipate closing by June 30, 2026, subject to remaining conditions.